PMID: 6788167Jun 20, 1981Paper

Controlled trial of biofeedback-aided behavioural methods in reducing mild hypertension

British Medical Journal
C PatelD J Terry

Abstract

Employees of a large industry were screened for the presence of coronary risk factors. A total of 204 employees, aged 35-64 years, with two or more such factors (serum cholesterol concentration greater than or equal to 6.3 mmol/l (243.6 mg/100 ml), blood pressure greater than or equal to 140/90 mm Hg, and current cigarette consumption greater than or equal to 10 cigarettes a day) were randomly allocated to a biofeedback group receiving training in relaxation and management of stress or a control group. Both groups received simple health education literature. After eight weeks of training, and again eight months later, the biofeedback group showed a significantly greater fall in systolic and diastolic blood pressures than the control group (p less than 0.001). Plasma renin activity and plasma aldosterone concentration were measured in a subsample at entry to the study and again at eight weeks and eight months; both showed a greater reduction in the biofeedback compared with the control group at eight weeks' follow-up. The greater reduction in blood pressure in the subjects in the biofeedback group compared with the control group (11.0 mm Hg systolic and 8.8 mm Hg diastolic), persisting eight months after the training, suggests t...Continue Reading

References

Jan 1, 1978·General Pharmacology·W S Peart
Mar 1, 1977·Archives of General Psychiatry·C B TaylorS Agras
Oct 1, 1977·American Journal of Public Health·R K PetersJ M Peters
Feb 1, 1975·Circulation·D A Kristt, B T Engel
Feb 1, 1975·Behaviour Research and Therapy·J E Shoemaker, D L Tasto
Jan 8, 1976·The New England Journal of Medicine·R A Stone, J DeLeo
Oct 1, 1973·The American Journal of Clinical Hypnosis·H L DeablerS T Elder
Jun 1, 1969·Angiology·K K DateyS L Vinekar
Sep 4, 1980·The New England Journal of Medicine·L LuborskyK Engelman
Oct 1, 1973·Journal of Applied Behavior Analysis·S T Elder, Z R Ruiz

❮ Previous
Next ❯

Citations

Sep 1, 1989·Biofeedback and Self-regulation·L K PearceJ R Burton
Jun 1, 1991·Biofeedback and Self-regulation·E B BlanchardV V Khramelashvili
Jun 1, 1988·Biofeedback and Self-regulation·G C McCoyT P Pallmeyer
Jan 1, 1988·Journal of Community Health·J M TschannD S Gullion
Dec 1, 1994·Biofeedback and Self-regulation·P M LehrerR L Woolfolk
Dec 1, 1989·Cardiovascular Drugs and Therapy·K Arakawa
Jan 17, 2009·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·S ElhaniR Atiqi
Dec 2, 2009·Applied Psychophysiology and Biofeedback·Erik M G OlssonAta Ghaderi
Oct 30, 1987·The American Journal of Cardiology·V Vertes
Jan 1, 1985·Journal of Psychosomatic Research·D W Johnston
Jan 1, 1986·Journal of Psychosomatic Research·M J IrvineG V Marie
Jan 1, 1982·Social Science & Medicine·J P Henry
Jan 1, 1984·Psychological Medicine. Monograph Supplement·A Mann
Jun 13, 2008·Journal of Human Hypertension·Ho DickinsonJm Mason
Mar 13, 2002·Public Health Reports·G DaumitR S Lawrence
Jun 11, 2010·American Journal of Therapeutics·R AtiqiTon J Cleophas
Jun 21, 2001·The Journal of Clinical Hypertension·T G Pickering
Oct 9, 1982·British Medical Journal·D Johnston, A Steptoe
Oct 13, 1984·British Medical Journal·G Andrews
Apr 13, 1985·British Medical Journal·C PatelM Patel
Nov 5, 1988·BMJ : British Medical Journal·L R BridgeR G Priest
May 26, 1990·BMJ : British Medical Journal·G A van MontfransA J Dunning
Apr 10, 1993·BMJ : British Medical Journal·D W JohnstonB Robinson
Mar 1, 1991·Postgraduate Medical Journal·G W Ching, D G Beevers
Mar 29, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Mutsuhiro NakaoTomifusa Kuboki
Oct 16, 2013·Psychosomatic Medicine·Joel W HughesRichard Josephson
Apr 21, 2012·International Journal of Hypertension·Carly M GoldsteinJoel W Hughes
Oct 5, 1984·The American Journal of Medicine·N M Kaplan
Feb 18, 2010·Journal of Hypertension·Pietro Amedeo ModestiSaulo Sirigatti
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·M M Delmonte
May 8, 2013·Indian Heart Journal·Harinder K Bali
Sep 18, 1987·The American Journal of Cardiology·G A MacGregor
Mar 27, 2002·Preventive Medicine·L Ebony BoulwareNeil R Powe
Jan 28, 2015·Journal of Ayurveda and Integrative Medicine·Prakash MashyalNagarathna Raghuram
Jan 1, 1987·Health Education Quarterly·R P Sloan
Oct 4, 1996·American Journal of Health Promotion : AJHP·L R Murphy
Jan 1, 1989·International Quarterly of Community Health Education·D R Black, J T Hultsman
Feb 20, 2004·Journal of Human Hypertension·B WilliamsUNKNOWN British Hypertension Society

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.